A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population
Clinical trial NCT05708235 · RECRUITING
Trial details
- NCT number
- NCT05708235
- Sponsor
- MedSIR
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2028-06-30
- Enrollment
- 976
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.